Final confirmation of inefficiency of antibiotics in secondary prevention of coronary heart disease. Results of PROVE IT (gatifloxacin trial) and ACES
Pokrovskaia, E.V.
Kardiologiia 44(10): 82-83
2004
ISSN/ISBN: 0022-9040 PMID: 15477798 Document Number: 570069
Document emailed within 1 workday
Related Documents
Enbergs, A.; Liese, A.; Heimbach, M.; Kerber, S.; Scheld, H.H.; Breithardt, G.; Kleine-Katthöfer, P.; Keil, U. 1997: Evaluation of secondary prevention of coronary heart disease. Results of the EUROSPIRE study in the Munster region Zeitschrift für Kardiologie 86(4): 284-291Assmann, G. 1999: Secondary coronary heart disease prevention by red wine? Der Internist 40(9): 982
Wilhelmsen, L. 1982: Secondary prevention of coronary heart disease. A review Cor et Vasa 24(4): 216-227
Jenni, D.; Osterwalder, R.; Osswald, S.; Buser, P.; Pfisterer, M. 2001: Are we treating coronary heart disease and heart failure appropriately in the clinic and ambulatory care? Secondary prevention and drug therapy 1998 Praxis 90(41): 1759-1765
Meinertz, T.; Heitzer, T. 2002: Primary and secondary prevention of coronary heart disease: smoking Zeitschrift für Kardiologie 91 Suppl. 2: 3-11
2007: Intervention with clarithromycin in patients with stable coronary heart disease--the CLARICOR trial: secondary publication Ugeskrift for Laeger 169(6): 497-499
Lindbloom, E.J.; Eaton, L.J. 2002: Cost effectiveness of aspirin vs clopidogrel for secondary prevention of coronary heart disease Journal of Family Practice 51(9): 789
Wilhelmsen, L. 1977: Primary and secondary risk factors for coronary heart disease: their role in prevention Medical Journal of Malaysia 31(4): 296-301
Carneiro, Aónio.Vaz.; Costa, Jão.; Borges, M. 2004: Statins for primary and secondary prevention of coronary heart disease. A scientific review Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 23(1): 95-122
Jost, S.; Lichtlen, P.R. 1995: Modifying increased plasma cholesterol levels in secondary prevention of coronary heart disease Zeitschrift für Kardiologie 84(8): 577-595
Arnheim, K. 2000: Coronary heart disease: grave deficiencies in secondary prevention. Almost no one is concerned with blood lipids MMW Fortschritte der Medizin 142(24): 18
McKenna, C.J.; Sugrue, D.D. 1995: Secondary prevention in coronary heart disease. Fact: lowering cholesterol saves lives Irish Medical Journal 88(6): 191
1975: An international controlled trial in multifactorial prevention of coronary heart disease (author transl) Przeglad Lekarski 32(6): 495-502
Aronov, D.M.; Krasnitskiĭ, V.B.; Bubnova, M.G.; Posdniakov, I.M.; Ioseliani, D.V.; Shchegol'kov, A.N.; Efremushkin, G.G.; Osipova, I.V.; Guliaeva, S.F.; Mal'chikova, S.V.; Kazakevich, E.V.; Liamina, N.P.; Riamzina, I.N.; Mingazetdinova, L.N. 2006: Exercise in outpatient complex rehabilitation and secondary prophylaxis in patients with ischemic heart disease after acute coronary events (a cooperative trial in Russia) Terapevticheskii Arkhiv 78(9): 33-38
Steinbach, M.; Constantineanu, M.; Harnagea, P.; Theodorini, S.; Georgescu, M.; Mitu, S.; Tănăseanu, S.; Tănăsescu, C.; Teodorescu, S.; Voiculescu, M.; Voiosu, R.; Cucu, F.; Suciu, A.; Schioiu, L.; Ciobanu, F.; Chirulescu, Z.; Schiau, M.; Cherciu, M.; Stoica, V.; David, D.; Stănescu, C.; Stefănescu, S.; Ionescu, A. 1982: The Bucharest multifactorial prevention trial of coronary heart disease. General methodology and risk factor correction after five year follow-up (1971-1977) Medecine Interne 20(2): 117-136
Cucu, F.; Purice, S.; Schioiu-Costache, L.; Damşa, T.; Suciu, A.; Cherciu, A.; Steinbach, M. 1991: Seasonal variations of serum cholesterol detected in the Bucharest Multifactorial Prevention Trial of Coronary Heart Disease. Ten years follow-up (1971-1982) Romanian Journal of Internal Medicine 29(1-2): 15-21
Kittel, F.; Kornitzer, M.; De Backer, G.; Dramaix, M. 1982: The Belgian Heart Disease Prevention Project: type A behavior pattern and the prevalence of coronary heart disease Activitas Nervosa Superior Suppl. 3(Pt 1): 78-83
Zhang, H.; Jiang, Y.; Nguyen, H.D.; Poo, D.Chiang.Choon.; Wang, W. 2017: The effect of a smartphone-based coronary heart disease prevention (SBCHDP) programme on awareness and knowledge of CHD, stress, and cardiac-related lifestyle behaviours among the working population in Singapore: a pilot randomised controlled trial Health and Quality of Life Outcomes 15(1): 49
Arntz, H.R.; Wunderlich, W.; Schnitzer, L.; Stern, R.; Fischer, F.; Agrawal, R.; Linderer, T.; Schultheiss, H.P. 1999: Short- and long-term effects of intensified versus conventional antilipidemic therapy in patients with coronary heart disease. Results from the Lipid-Coronary Artery Disease (L-CAD) Study Zeitschrift für Kardiologie 88(8): 582-590
Samuelsson, O.G.; Wilhelmsen, L.W.; Pennert, K.M.; Wedel, H.; Berglund, G.L. 1990: The J-shaped relationship between coronary heart disease and achieved blood pressure level in treated hypertension: further analyses of 12 years of follow-up of treated hypertensives in the Primary Prevention Trial in Gothenburg, Sweden Journal of Hypertension 8(6): 547-555